Access cutting-edge hypertrophic cardiomyopathy treatment through this clinical trial at a research site in Philadelphia. Study-provided care at no cost to qualified participants.
Access hypertrophic cardiomyopathy specialists in Philadelphia at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hypertrophic cardiomyopathy treatment provided free
This is a first-in-human, non-randomized, open-label study designed to evaluate the safety, tolerability, and pharmacodynamics (PD) of TN-201 in adult patients with symptomatic hypertrophic cardiomyopathy (HCM) caused by mutations in the MYBPC3 gene.
Sponsor: Tenaya Therapeutics
Check if you qualify for this hypertrophic cardiomyopathy clinical trial in Philadelphia, PA
If you're searching for hypertrophic cardiomyopathy treatment options in Philadelphia, PA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Philadelphia research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hypertrophic cardiomyopathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.